Abstract
Primary Sjögren's syndrome (SjS) is a systemic autoimmune disease that is associated with early and gradually progressive lacrimal and salivary dysfunction. Secondary SjS occurs in association with other autoimmune disorders, the most common of which is rheumatoid arthritis. About 90% of patients with SjS are women. Minor salivary glands and lacrimal glands in SjS exhibit a particular pattern of periductal focal lymphocytic infiltration known as focal lymphocytic sialadenitis. Primary SjS has a community prevalence that ranges from 0.1 to 0.6%. The major eye problem in SjS is keratoconjunctivitis sicca, which leads to xerophthalmia. The principal oral manifestation of SjS is decreased salivary gland production, leading to xerostomia and a predilection for dental caries. Extraglandular manifestations of SjS include arthral-gias, thyroiditis, renal involvement (leading to renal tubular acidosis (RTA)), peripheral neuropathy, cutaneous vasculitis, and lymphoma. The risk of lymphoma in SjS is approximately 5%. Most patients with SjS develop increased circulating polyclonal immunoglobulins and autoantibodies. These autoantibodies include two fairly specific antibodies directed against the Ro (SS-A) and La (SS-B) antigens.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abraham CM, al-Hashimi I, Haghighat N. Evaluation of the levels of oral Candida in patients with Sjögren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;86:65–8
Alexander E, Arnett F, Provost T, Stevens MB. Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hemato-logic abnormalities, and serologic hyperactivity. Ann Intern Med. 1983;98:155–9
Alexander EL, Beall SjS, Gordon B, et al Magnetic resonance imaging of cerebral lesions in patients with the Sjögren syndrome. Ann Intern Med. 1988;108:815–23
Almstahl A, Kroneld U, Tarkowski A, Wikstrom M. Oral microbial flora in Sjögren's syndrome. J Rheumatol. 1999;26:110–4
Andonopoulos AP, Drosos AA, Skopouli FN, Acritidis NC, Moutsopoulos HM. Secondary Sjögren's syndrome in rheumatoid arthritis. J Rheumatol. 1987;14:1098–103
Andonopoulos AP, Drosos AA, Skopouli FN, Moutsopoulos HM. Sjögren's syndrome in rheumatoid arthritis and progressive systemic sclerosis. A comparative study. Clin Exp Rheumatol. 1989;7: 203–5
Aoki N. Klinefelter's syndrome, autoimmunity, and associated endo-crinopathies. Intern Med. 1999;38:838–9
Atalar K, Afzali B, Lams B, et al Falls, hypokalaemia, and a dry mouth. Lancet. 2007;370(9582):192
Belafsky PC, Postma GN. The laryngeal and esophageal manifestations of Sjögren's syndrome. Curr Rheumatol Rep. 2003;5:297–303
Bloch KJ, Buchanan WW, Wohl MJ, Bunim JJ. Sjögren's syndrome. A clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore). 1965;44:187–231
Boki KA, Ioannidis JP, Segas JV, et al How significant is sensorineural hearing loss in primary Sjögren's syndrome? J Rheumatol. 2001;28: 798–801
Bossini N, Savoldi S, Franceschini F, et al Clinical and morphological features of kidney involvement in primary Sjögren's syndrome. Nephrol Dial Transplant. 2001;16:2328–36
Boutsi EA, Paikos S, Dafni UG, et al Dental and periodontal status of Sjögren's syndrome. J Clin Periodontol. 2000;27:231–5
Bowman SK, Ibrahim GH, Holmes G, et al Estimating the prevalence among Caucasian women of primary Sjögren's syndrome in two general practices in Birmingham, UK Scand J Rheumatol. 2004;33: 39–43
Brito-Zerón P, Ramos-Casals M, Bove A, et al Predicting adverse outcomes in primary Sjögren's syndrome: identification of prognostic factors. Rheumatology (Oxford). 2007;46(8):1359–62
Brito-Zerón P, Ramos-Casals M, Nardi N, et al Circulating monoclonal immunoglobulins in Sjögren syndrome: prevalence and clinical significance in 237 patients. Medicine (Baltimore). 2005;84(2): 90–7
Brito-Zerón P, Soria N, Muñoz S, et al Prevalence and clinical relevance of autoimmune neutropenia in patients with primary Sjögren's syndrome. Semin Arthritis Rheum. 2008;38(5):389–95
Caporali R, Bonacci E, Epis O, et al Safety and usefulness of minor salivary gland biopsy: retrospective analysis of 502 procedures performed at a single center. Arthritis Rheum. 2008;59:714–20
Chai J, Herrmann DN, Stanton M, et al Painful small-fiber neuropathy in Sjögren's syndrome. Neurology. 2005;65:925–7
Collard RC, Koehler RP, Mattson DH. Frequency and significance of antinuclear antibodies in multiple sclerosis. Neurology. 1997;49: 857–61
Coppo P, Sibilia J, Maloisel F, et al Primary Sjögren's syndrome associated agranulocytosis: a benign disorder? Ann Rheum Dis. 2003;62: 476–8
Cummings NA, Schall GL, Asofski R. Sjögren's syndrome. New aspects of research, diagnosis and therapy. Ann Intern Med. 1971;75: 937
Dafni UG, Tzioufas AG, Staikos P, et al Prevalence of Sjögren's syndrome in a closed rural community. Ann Rheum Dis. 1997;56: 521–5
Daniels T, Greenspan JS, Cox D, Criswell LA, DeSouza Y, Dong Y, et al Objective measures in Sjögren's syndrome are strongly associated with each other but not with sicca symptoms: analysis of 564 enrollees in the SICCA international registry and repository. Arthritis Rheum. 2007;56 Suppl:S446
Daniels T, Whitcher J. Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren's syndrome. Arthritis Rheumatol. 1994;37:869–77
Daniels TE. Benign lymphoepithelial lesion and Sjögren's syndrome. Ch 6. In Ellis GL, Auclair PL, Gnepp DR, editors. Surgical pathology of the salivary glands. Philadelphia: W.B.Saunders; 1991. p. 83–106
Daniels TE, Fox PC. Salivary and oral components of Sjögren's syndrome. Rheum Dis Clin North Am. 1992;18(3):571–89
Daniels TE, Silverman S, Michalski JP, Greenspan JS, Sylvester RA, Talal N. The oral component of Sjögren's syndrome. Oral Surg Oral Med Oral Pathol. 1975;39:875–85
Daniels TE. Evaluation, differential diagnosis, and treatment of xerostomia. J Rheumatol. 2000;27(Suppl 61):6–10
Davidson BK, Kelly CA, Griffiths ID. Ten year follow up of pulmonary function in patients with primary Sjögren's syndrome. Ann Rheum Dis. 2000;59:709–12
Dawson LJ, Caulfield VL, Stanbury JB, et al Hydroxychloroquine therapy in patients with primary Sjögren's syndrome may improve salivary gland hypofunction by inhibition of glandular cholinesterase. Rheumatology (Oxford). 2005;44:449–55
Delalande S, de Seze J, Fauchais AL. Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore). 2004;83:280–91
Denislic M, Meh D. Early asymmetric neuropathy in primary Sjögren's syndrome. J Neurol. 1997;244(6):383–7
Drosos AA, Voulgari PV, Psychos DN, Tsifetaki N, Bai M. Sicca syndrome in patients with sarcoidosis. Rheumatol Int. 1999;18: 177–80
Dyck PJ. The clinical heterogeneity of immune sensory and autonomic neuropathies with (or without) sicca. Brain. 2005;128(Pt 11): 2480–2
Ferreira S, D'Cruz DP, Hughes GR. Multiple sclerosis, neuropsychiat-ric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford). 2005;44:434–42
Font J, Ramos-Casals M, Cervera R, et al Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: prevalence and clinical significance. Br J Rheumatol. 1998;37(12):1287–91
Font J, Ramos-Casals M, de la Red G, et al Pure sensory neuropathy in primary Sjögren's syndrome. Longterm prospective followup and review of the literature. J Rheumatol. 2003;30(7):1552–7
Forstot JZ, Forstot SL, Greer RO, Tan EM. The incidence of Sjögren's sicca complex in a population of patients with keratoconjunctivitis sicca. Arthritis Rheumat. 1982;25:156–60
Fox RI, Stern M. Sjögren's syndrome: mechanisms of pathogenesis involve interaction of immune and neurosecretory systems. Scand J Rheumatol Suppl 2002;(116):3–13
Franquet T, Diaz C, Domingo P, et al Air trapping in primary Sjögren syndrome: correlation of expiratory CT with pulmonary function tests. J Comput Assist Tomogr. 1999;23:169–73
Freeman SR, Sheehan PZ, Thorpe MA, Rutka JA. Ear, nose, and throat manifestations of Sjögren's syndrome: retrospective review of a multidisciplinary clinic. J Otolaryngol. 2005;34(1):20–4
García-Carrasco M, Ramos-Casals M, et al Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002a;81(4):270–80
García-Carrasco M, Sisó A, Ramos-Casals M, et al Raynaud's phenomenon in primary Sjögren's syndrome. Prevalence and clinical characteristics in a series of 320 patients. J Rheumatol. 2002b;29: 726–30
Gerli R, Muscat C, Giansanti M, et al Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. Br J Rheumatol. 1997;36:969–75
Gøransson LG, Herigstad A, Tjensvoll AB, et al Peripheral neuropathy in primary Sjögren syndrome: a population-based study. Arch Neurol. 2006;63:1612–5
Gorson KC, Ropper AH. Muscle Nerve 2003; 28(5):553–60. Positive salivary gland biopsy, Sjögren syndrome, and neuropathy: clinical implications
Gorson KC, Natarajan N, Ropper AH, Weinstein R. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Muscle Nerve 2007; 35(1):66–9
Goules A, Masouridi S, Tzioufas AG, et al Clinically significant and biopsy-documented renal involvement in primary Sjögren's syndrome. Medicine (Baltimore). 2000;79:241–9
Hakansson U, Jacobsson L, Lilja B, et al Salivary gland scintigraphy in subjects with and without symptoms of dry mouth and/or eyes, and, in patients with primary Sjögren's syndrome. Scand J Rheumatol. 1994;23:326–33
Helman J, Turner RJ, Fox PC, Baum BJ. 99mTc-pertechnetate uptake in parotid acinar cells by the Na + /K + /Cl- co- transport system. J Clin Invest. 1987;79:1310–3
Hernandez YL, Daniels TE. Oral candidiasis in Sjögren's syndrome: prevalence, clinical correlations, and treatment. Oral Surg Oral Med Oral Pathol. 1989;3:324–9
Hershkovich O, Shafat I, Nagler RM. Age-related changes in salivary antioxidant profile: possible implications for oral cancer. J Gerontol A Biol Sci Med Sci. 2007;62:361–6
Hyer S, Kong A, Pratt B, et al Salivary gland toxicity after radioiodine therapy for thyroid cancer. Clin Oncol (R Coll Radiol). 2007;19: 83–6
Ioannidis JP, Moutsopoulos HM. Sjögren's syndrome: too many associations, too limited evidence. The enigmatic example of CNS involvement. Semin Arthritis Rheum. 1999;29:1–3
Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum. 2002;46:741–7
Jacobsson LT, Axell TE, Hansen BU, et al Dry eyes or mouth: an epide-miological study in Swedish adults, with special reference to primary Sjögren's syndrome. J Autoimmun. 1989;2:521–7
Jara LJ, Navarro C, Brito-Zeron P, et al Thyroid disease in Sjögren's syndrome. Clin Rheumatol. 2007;26:1601–6
Jungehulsing M, Fischbach R, Schroder U, et al Magnetic resonance sialography. Otolaryngol Head Neck Surg. 1999;121:488–94
Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol. 2006;41:613–25
Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR, Costa J, Decker JL, Chused TM. Increased risk of lymphoma in sicca syndrome. Ann Intern Med. 1978;89:888–92
Kohler PF, Winter ME. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum 1985; 28:1128–32
Kohn WG, Ship JA, Atkinson JC, et al Salivary gland 99mTc-scintigra-phy: a grading scale and correlation with major salivary gland flow rates. J Oral Pathol Med. 1992;21:70–4
Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev. 2007;220:251–69
Kruize AA, Hené RJ, Kallenberg CG, et al Hydroxychloroquine treatment for primary Sjögren's syndrome: a two year, double-blind crossover trial. Ann Rheum Dis. 1993;52:360–4
Kruize AA, Hene RJ, van der Heide A, Bodeutsch C, deWilde PCM, vanBijsterveld OP, et al Long-term followup of patients with Sjögren's syndrome. Arthritis Rheum. 1996;297–303
Lamour A, Le Corre R, Pennec YL, Cartron J, Youinou P. Heterogeneity of neutrophil antibodies in patients with primary Sjögren's syndrome. Blood. 1995;86:3553–9
Larsson X, Bredberg A, Henriksson G, Manthorpe R, Sallmyr A. Immunohistochemistry of the B cell component in lower lip salivary glands of Sjögren's syndrome and healthy subjects. Scand J Immunol. 2005;61:98–107
Lekhanont K, Leyngold IM, Suwan-Apichon O, et al Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model. Cornea. 2007;26: 84–9
Leppilahti M, Tammela TL, Huhtala H, et al Interstitial cystitis-like urinary symptoms among patients with Sjögren's syndrome: a population-based study in Finland. Am J Med. 2003;115:62–5
Liang L, Zhang M, Zou W, Liu Z. Aggravated dry eye after laser in situ keratomileusis in patients with Sjögren syndrome. Cornea. 2008;27: 120–3
Makula E, Pokorny G, Kiss M, et al The place of magnetic resonance and ultrasonographic examinations of the parotid gland in the diagnosis and follow-up of primary Sjögren's syndrome. Rheumatology (Oxford). 2000;39:97–104
Maltsman-Tseikhin A, Moricca P, Niv D. Burning mouth syndrome: will better understanding yield better management? Pain Pract. 2007; 7:151–62
Mandl T, Ekberg O, Wollmer P, et al Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjögren's syndrome. Scand J Rheumatol. 2007a;36:394–401
Mandl T, Wollmer P, Manthorpe R, Jacobsson LT. Autonomic and orthostatic dysfunction in primary Sjögren's syndrome. J Rheumatol. 2007b;34:1869–74
Manoussakis MN, Georgopoulou C, Zintzaras E, et al Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum. 2004;50:882–91
Mariette X, Agbalika F, Zucker-Franklin D, et al Detection of the tax gene of HTLV-I in labial salivary glands from patients with Sjögren's syndrome and other diseases of the oral cavity. Clin Exp Rheumatol. 2000;18:341–7
Mariette X, Ravaud P, Steinfeld S, et al Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled trial of remicade in primary Sjögren's syndrome (TRIPSjS). Arthritis Rheum. 2004;50:1270–6
Mariette X, Roux S, Zhang J, et al The level of BlyS (BAFF) correlates with the titer of autoantibodies in human Sjögren's syndrome. Ann Rheum Dis. 2003;62:168–71
Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The management of Sjögren's syndrome. Nat Clin Pract Rheumatol. 2006;2: 252–61
Mellgren SI, Goransson LG, Omdal R. Primary Sjögren's syndrome associated neuropathy. Can J Neurol Sci. 2007;34:280–7
Mikulicz J. Über eine eigenartige symmetrische Erkrankung der Tranen und Mundspeicheldrusen. Stuttgart: Beitr Chir Fortsch Gewidmet Theodor Billroth. 1892;610–30
Mitsias D, Tzioufas A, Veiopoulou C, et al The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjögren's syndrome. Clin Exp Immunol. 2002;128:562–8
Mori K, Iijima M, Sugiura M et al Sjögren's syndrome associated painful sensory neuropathy without sensory ataxia. J Neurol Neurosurg Psychiatry 2003; 74(9):1320–2
Mori K, Iijima M, Koike H, et al The wide spectrum of clinical manifestations in Sjögren's syndrome-associated neuropathy. Brain. 2005;128:2518–34
Moutsopoulos HM, Balow JE, Lawley TJ, et al Immune complex glom-erulonephritis in sicca syndrome. Am J Med. 1978;64:955–60
Moutsopoulos HM, Elkon KB, Mavridis AK, et al Serum C-reactive protein in primary Sjögren's syndrome. Clin Exp Rheumatol. 1983a;1:57–8
Moutsopoulos HM, Webber BL, Vlagopoulos TP, et al Differences in the clinical manifestations of sicca syndrome in the presence and absence of rheumatoid arthritis. Am J Med. 1979;66:733–6
Moutsopoulos HM, Steinberg AD, Fauci AS, et al High incidence of free monoclonal lambda light chains in the sera of patients with Sjögren's syndrome. J Immunol. 1983b;130:2663–5
Moutsopoulos HM, Costello R, Drosos AA, et al Demonstration and identification of monoclonal proteins in the urine of patients with Sjögren's syndrome. Ann Rheum Dis. 1985;44:109–12
Nagler RM. Salivary glands and the aging process: mechanistic aspects, health-status and medicinal-efficacy monitoring. Biogerontology. 2004;5:223–33
Nakamura H, Kawakami A, Tominaga M, et al Relationship between Sjögren's syndrome and human T-lymphotropic virus type I infection: follow-up study of 83 patients. J Lab Clin Med. 2000;135: 139–44
Nardi N, Brito-Zerón P, Ramos-Casals M, et al Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome: prevalence and clinical significance in 335 patients. Clin Rheumatol. 2006;25(3):341–6
Papiris SA, Maniati M, Constantopoulos SH, et al Lung involvement in primary Sjögren's syndrome is mainly related to the small airway disease. Ann Rheum Dis. 1999;58:61–4
Paschides CA, Kitsios G, Karakostas KX, et al Evaluation of tear break-up time, Schirmer's-I test and rose bengal staining as confirmatory tests for keratoconjunctivitis sicca. Clin Exp Rheumatol. 1989;7:155–7
Patton LL, Siegel MA, Benoliel R, De Laat A. Management of burning mouth syndrome: systematic review and management recommendations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103 Suppl:S39.e1–13
Pavlidis NA, Karsh J, Moutsopoulos HM. The clinical picture of primary Sjögren's syndrome: a retrospective study. J Rheumatol. 1982;9: 685–90
Pertovaara M, Pukkala E, Laippala P, et al A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis. 2001; 60:467–72
Pflugfelder SC, Maskin SL, Anderson B, et al A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol. 2004;138:444–57
Pillemer SR, Smith J, Fox PC, Bowman SJ. Outcome measures for Sjögren's syndrome. J Rheumatol. 2005;32:143–9
Prochorec-Sobieszek M, Wagner T, Loukas M, Chwali ska-Sadowska H, Olesi ska M. Histopathological and immunohistochemical analysis of lymphoid follicles in labial salivary glands in primary and secondary Sjögren's syndrome. Med Sci Monit. 2004;10: BR115–21
Ramos-Casals M, Anaya JM, García-Carrasco M, et al Cutaneous vascu-litis in primary Sjögren syndrome: classification and clinical signifi-cance of 52 patients. Medicine (Baltimore). 2004a;83(2): 96–106
Ramos-Casals M, Font J, Garcia-Carrasco M, et al Primary Sjögren syndrome: hematologic patterns of disease expression. Medicine (Baltimore). 2002;81(4):281–92
Ramos-Casals M, García-Carrasco M, Cervera R, et al Thyroid disease in primary Sjögren syndrome: study in a series of 160 patients. Medicine (Baltimore). 2000;79(2):103–8
Ramos-Casals M, la Civita L, De Vita S, et al For the SjS-HCV Study Group. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection. Arthritis Rheum. 2007;57(1):161–70
Ramos-Casals M, Loustaud-Ratti V, De Vita S, et al For the Sjögren syndrome associated with hepatitis C virus: a multicenter analysis of 137 cases. Medicine (Baltimore). 2005;84(2):81–9
Ramos-Casals M, Nardi N, Brito-Zerón P, et al Atypical autoantibodies in patients with primary Sjögren syndrome: clinical characteristics and follow-up of 82 cases. Semin Arthritis Rheum. 2006a; 35(5): 312–21
Ramos-Casals M, Sánchez-Tapias JM, Parés A, et al Characterization and differentiation of autoimmune versus viral liver involvement in patients with Sjögren's syndrome. J Rheumatol. 2006b;33(8): 1593–9
Ramos-Casals M, Solans R, Rosas J, et al Primary Sjögren syndrome in Spain: clinical and immunologic expression of 1010 patients. Medicine (Baltimore). 2008;87(4):210–9
Reinertsen JL, Schaefer EJ, Brewer HB, Moutsopoulos HM. Sicca-like syndrome in type V hyperlipoproteinemia. Arthritis Rheum. 1980;23: 114–8
Rhodus NL, Michalowicz BS. Periodontal status and sulcular Candida albicans colonization in patients with primary Sjögren's syndrome. Quintessence Int. 2005;36(3):228–33
Salliot C, Gottenberg JE, Bengoufa D, et al Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome. J Rheumatol. 2007;34(11):2253–8
Sankar V, Brennan MT, Kok MR, et al Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum. 2004;50:2240–5
Simon BG, Moutsopoulos HM. Primary amyloidosis resembling sicca syndrome. Arthritis Rheum. 1979;22:932–4
Sjögren's Syndrome Foundation. And the survey says. The Moisture Seekers. 2006;24:1–3
Skopouli FN, Barbatis C, Moutsopoulos HM. Liver involvement in primary Sjögren's syndrome. Br J Rheumatol. 1994a;33:745–8
Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjögren's syndrome. Semin Arthritis Rheum. 2000;29:296–304
Skopouli FN, Papanikolaou S, Malamou-Mitsi V, et al Obstetric and gynaecological profile in patients with primary Sjögren's syndrome. Ann Rheum Dis. 1994b;53:569–73
Skopouli FN, Talal A, Galanopoulou V, et al Raynaud's phenomenon in primary Sjögren's syndrome. J Rheumatol. 1990;17:618–20
Stevens WJ, Swartele FE, Empsten FA, De Clerck LS. Use of the Saxon test as a measure of saliva production in a reference population of schoolchildren. Am J Dis Child. 1990;144:570–1
Stojanovich L, Milovanovich B, de Luka SR, et al Cardiovascular auto-nomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjögren syndrome and other autoimmune diseases. Lupus. 2007;16: 181–5
Takeda S, Haratake J, Kasai T, et al IgG4-associated idiopathic tubu-lointerstitial nephritis complicating autoimmune pancreatitis. Nephrol Dial Transplant. 2004;19:474–6
Taouli B, Brauner MW, Mourey I, et al Thin-section chest CT findings of primary Sjögren's syndrome: correlation with pulmonary function. Eur Radiol. 2002;12:1504–11
Terrier B, Lacroix C, Guillevin L, et al Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjögren's syndrome-related neuropathy. Arthritis Rheum. 2007;57(8):1520–9
Theander E, Manthorpe R, Jacobsson L. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study. Arthritis Rheum. 2004;50:1262–9
Tishler M, Yaron I, Shirazi I, Yaron M. Hydroxychloroquine treatment for primary Sjögren's syndrome: its effect on salivary and serum inflammatory markers. Ann Rheum Dis. 1999;58:253–6
Trontzas PI, Andrianakos AA. Sjögren's syndrome: a population based study of prevalence in Greece. Ann Rheum Dis. 2005;64:1240–1
Tsampoulas CG, Skopouli FN, Sartoris DJ, et al Hand radiographic changes in patients with primary and secondary Sjögren's syndrome. Scand J Rheumatol. 1986;15:333–9
Tsianos EB, Chiras CD, Drosos AA, Moutsopoulos HM. Oesophageal dysfunction in patients with primary Sjögren's syndrome. Ann Rheum Dis. 1985;44:610–3
Tsianos EB, Tzioufas AG, Kita MD, et al Serum isoamylases in patients with autoimmune rheumatic diseases. Clin Exp Rheumatol. 1984;2: 235–8
Tzioufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum. 1996;39:767–72
Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993;36: 340–7
Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron Y, et al Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. Ann Rheum Dis. 1996;55:116–21
Vitali C, Bombardieri Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis. 2002;61:544–58
Vivino FB, Gala I, Hermann GA. Change in final diagnosis on second evaluation of labial minor salivary gland biopsies. J Rheumatol. 2002;29:938–44
Voulgarelis M, Dafni UG, Isenberg DA, Mousopoulos HM. Malignant lymphoma in primary Sjögren's syndrome. A multicenter, retrospective, clinical study by the European concerted action on Sjögren's syndrome. Arthritis Rheum. 1999;42:1765–72
Voulgarelis M, Giannouli S, Tzioufas AG, Moutsopoulos HM. Long term remission of Sjögren's syndrome associated aggressive B cell non-Hodgkin's lymphomas following combined B cell depletion therapy and CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone). Ann Rheum Dis. 2006;65:1033–7
Walker J, Gordon T, Lester S, et al Increased severity of lower urinary tract symptoms and daytime somnolence in primary Sjögren's syndrome. J Rheumatol. 2003;30:2406–12
Whitcher J, Gritz D, Daniels T. The dry eye: a diagnostic dilemma. Int Ophthal Clin. 1998;38:23–37
Wolkoff P, Nojgaard JK, Franck C, Skov P. The modern office environment desiccates the eyes? Indoor Air. 2006;16:258–65
Wright SA, Convery RP, Liggett N. Pulmonary involvement in Sjögren's syndrome. Rheumatology (Oxford). 2003;42:697–8
Wu AJ, Fox PC. Sjögren's syndrome. Semin Dermatol. 1994;13:138–43
Yamamoto M, Takahashi H, Sugai S, Imai K. Clinical and pathological characteristics of Mikulicz's disease (IgG4-related plasmacytic exo-crinopathy). Autoimmun Rev. 2005;4:195–200
Zandbelt MM, de Wilde P, van Damme P, et al Etanercept in the treatment of patients with primary Sjögren's syndrome: a pilot study. J Rheumatol. 2004;31:96–101
Zintzaras E, Voulgarelis M, Moutsopoulos H. The risk of lymphoma development in autoimmune diseases. Arch Intern Med. 2005; 165:2337–44
Klippel JH, Stone JS, Crofford L, White P. Primer on the Rheumatic Diseases. 13th Edition. 2008. Springer. London
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Ramos-Casals, M. et al. (2009). Sjögren's Syndrome. In: Stone, J.H. (eds) A Clinician's Pearls and Myths in Rheumatology. Springer, London. https://doi.org/10.1007/978-1-84800-934-9_12
Download citation
DOI: https://doi.org/10.1007/978-1-84800-934-9_12
Publisher Name: Springer, London
Print ISBN: 978-1-84800-933-2
Online ISBN: 978-1-84800-934-9
eBook Packages: MedicineMedicine (R0)